Skip to content
Recall Observatory FDA recall evidence

Drug product

Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3333-01

D-0736-2021

July 29, 2021

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 88442
Status
Terminated
Classification
Class II
Quantity
16,644 vials
Official record key
drug-enforcement:D-0736-2021

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot #: 31329150B, exp. date 06/2022

Distribution pattern: Product was distributed Nationwide, including Puerto Rico.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility